SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Grants Soligenix Fast Track Designation for OrbeShield(™) for the Reduction of Mortality Associated With Gastrointestinal Acute Radiation Syndrome (GI ARS)